Rockefeller Capital Management’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
DGM
Rockefeller Capital Management's ABVX Position: Q3 2026 in Review
Rockefeller Capital Management increased its Abivax (ABVX) stake by 67% in Q3 2026, buying an estimated $964 and bringing the position to 20 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #4564.
Rockefeller Capital Management first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.88K in Q4 2025. 317 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- Rockefeller Capital Management held 20 shares of Abivax worth $1.98K as of Q3 2026.
- Rockefeller Capital Management bought 8 Abivax shares in Q3 2026, an estimated $964.
- Abivax made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4564 holding.
- Rockefeller Capital Management first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
- Rockefeller Capital Management's Abivax position peaked at $6.88K in Q4 2025.
- 317 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.